Cosentyx (secukinumab) safe, effective for treating psoriasis patients


Posted in: Drug Trial News | Medical Condition News

Tags: Anaphylaxis, Antibody, Arthralgia, Cancer, Candida, Cardiovascular Disease, Clinical Trial, Crohn’s Disease, Dermatology, Diarrhea, Exercise, Headache, Health Care, Healthcare, Hypersensitivity, Hypertension, Immunization, Inflammatory Disease, Light Therapy, Monoclonal Antibody, Neurological Disease, Pain, Placebo, Psoriasis, Respiratory, Respiratory Disease, Tuberculosis, Urticaria, Vaccines